Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H33NO2 |
Molecular Weight | 391.5457 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]4([H])[C@@]2([H])CC=C5C[C@H](CC[C@]45C)OC(C)=O
InChI
InChIKey=UVIQSJCZCSLXRZ-UBUQANBQSA-N
InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1
Molecular Formula | C26H33NO2 |
Molecular Weight | 391.5457 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:42:11 UTC 2023
by
admin
on
Fri Dec 15 15:42:11 UTC 2023
|
Record UNII |
EM5OCB9YJ6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
ZYTIGA (AUTHORIZED: PROSTATIC NEOPLASMS)
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
||
|
NCI_THESAURUS |
C147923
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DBSALT001173
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
1000818
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
68639
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
4176
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
DTXSID3049043
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
100000124155
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
748121
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
WW-52
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
C68845
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
1100071
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | RxNorm | ||
|
Abiraterone acetate
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
SUB31647
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
9821849
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
CHEMBL271227
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
m1279
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | Merck Index | ||
|
154229-18-2
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
749227
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
EM5OCB9YJ6
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY | |||
|
EM5OCB9YJ6
Created by
admin on Fri Dec 15 15:42:11 UTC 2023 , Edited by admin on Fri Dec 15 15:42:11 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INTERMEDIATE->PRODRUG |
|
||
|
METABOLIC ENZYME -> NON-SUBSTRATE |
|
||
|
TRANSPORTER -> INHIBITOR |
Abiraterone acetate inhibits Pgp significantly, with an IC50 of 10.8 μM in vitro.
IC50
|
||
|
TARGET -> INHIBITOR |
NEEDS TO BE ACTIVATE TO ABIRATERONE
|
||
|
EXCRETED UNCHANGED |
FECAL
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
|
|||